← FDA Drug Approvals (Drugs@FDA)

CLADRIBINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HISUN PHARM HANGZHOU · Approved 2019-11-25

Drug application

FDA Application #

ANDA210856

Application type

Abbreviated New Drug Application (Generic)

Brand name

CLADRIBINE

Generic name

CLADRIBINE

Active ingredients

CLADRIBINE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

HISUN PHARM HANGZHOU

Manufacturer

Hisun Pharmaceuticals USA, Inc.

First approval

2019-11-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown